Below are the most recent publications written about "Rectal Neoplasms" by people in Profiles.
-
Mirza MB, Gamboa AC, Irlmeier R, Hopkins B, Regenbogen SE, Hrebinko KA, Holder-Murray J, Wiseman JT, Ejaz A, Wise PE, Ye F, Idrees K, Hawkins AT, Balch GC, Khan A. Association of Surgical Approaches and Outcomes in Total Mesorectal Excision and Margin Status for Rectal Cancer. J Surg Res. 2024 Aug; 300:494-502.
-
Donovan KF, Lee KC, Ricardo A, Berger N, Bonaccorso A, Alavi K, Zaghiyan K, Pigazzi A, Sands D, DeBeche-Adams T, Chadi SA, McLemore EC, Marks JH, Maykel JA, Shawki SF, Steele SR, Albert M, Whiteford MH, Cheng FY, Wexner SD, Sylla P. Functional Outcomes After Transanal Total Mesorectal Excision (taTME) for Rectal Cancer: Results From the Phase II North American Multicenter Prospective Observational Trial. Ann Surg. 2024 Sep 01; 280(3):363-373.
-
Zewde MG, Peyser DK, Yu AT, Bonaccorso A, Moshier E, Alavi K, Goldstone R, Marks JH, Maykel JA, McLemore EC, Sands D, Steele SR, Wexner SD, Whiteford M, Sylla P. Oncologic outcomes following transanal total mesorectal excision: the United States experience. Surg Endosc. 2024 Jul; 38(7):3703-3715.
-
Hain E, Lef?vre JH, Ricardo A, Lee S, Zaghiyan K, McLemore E, Sherwinter D, Rhee R, Wilson M, Martz J, Maykel J, Marks J, Marcet J, Rouanet P, Maggiori L, Komen N, De Hous N, Lakkis Z, Tuech JJ, Attiyeh F, Cotte E, Sylla P. SafeHeal Colovac Colorectal Anastomosis Protection Device evaluation (SAFE-2) pivotal study: an international randomized controlled study to evaluate the safety and effectiveness of the Colovac Colorectal Anastomosis Protection Device. Colorectal Dis. 2024 Jun; 26(6):1271-1284.
-
Peponis T, Perry WRG, Kelley SR. Ischiorectal Fossa Tumors: 30-year Single-Institution Experience. Dis Colon Rectum. 2024 Jul 01; 67(7):896-902.
-
Sacks OA, Davids JS. Disparities in Rectal Cancer Care-What Are We Missing? JAMA Surg. 2023 11 01; 158(11):1203.
-
Bauer PS, Gamboa AC, Otegbeye EE, Chapman WC, Rivard S, Regenbogen S, Mohammed M, Holder-Murray J, Wiseman JT, Ejaz A, Edwards-Hollingsworth K, Hawkins AT, Hunt SR, Balch G, Silviera ML. Short-course radiation with consolidation chemotherapy does not increase operative morbidity compared to long-course chemoradiation: A retrospective study of the US rectal cancer consortium. J Surg Oncol. 2024 Feb; 129(2):254-263.
-
Welten VM, Dabekaussen KFAA, Miller MO, Yoo J, Irani JL, Goldberg JE, Bleday R, Reich AJ, Davids JS, Melnitchouk N. Patient Values and Goals Regarding Treatment for Rectal Cancer: a Mixed Methods Study. J Gastrointest Surg. 2023 12; 27(12):3088-3091.
-
Sylla P, Sands D, Ricardo A, Bonaccorso A, Polydorides A, Berho M, Marks J, Maykel J, Alavi K, Zaghiyan K, Whiteford M, Mclemore E, Chadi S, Shawki SF, Steele S, Pigazzi A, Albert M, DeBeche-Adams T, Moshier E, Wexner SD. Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results. Surg Endosc. 2023 12; 37(12):9483-9508.
-
Langenfeld SJ, Davis BR, Vogel JD, Davids JS, Temple LKF, Cologne KG, Hendren S, Hunt S, Garcia Aguilar J, Feingold DL, Lightner AL, Paquette IM. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer 2023 Supplement. Dis Colon Rectum. 2024 Jan 01; 67(1):18-31.